Boltz Raises $110M Series A; Open Drug-Design Models Pass 5M Downloads
GabriCorso · x · 2026-11-19
Boltz, a spinout from Regina Barzilay's MIT lab, announced a $110M Series A led by Bessemer Venture Partners, less than a year after leaving stealth with a $28M seed.
Boltz-1 was the first fully open-source model to reach AlphaFold 3-level accuracy; Boltz-2 added binding affinity prediction and BoltzGen designs protein binders. The open models have passed 5 million downloads, and molecular token usage has grown 50-fold since June. Six of the world's top 20 pharma companies use Boltz Lab.
The models stay free, with revenue from proprietary models, Boltz Lab and the API. The company moved from the US back to the UK and now has 40 AI researchers in its Kings Cross office in London.
More from Venture
- AI workflow startup Eachlabs announces $7M seed round co-led by EBRD and Revo VC — miilesus · 2026-11-19
- Listicle scaling doesn't last: SEOs watch mass-produced listicles lose rankings — gaganghotra_ · 2026-11-19
- Agentcard raises $8M to let agents buy from 5,000+ stores via Stripe Link — jeff_weinstein · 2026-11-19
- Anthropic's IPO is tomorrow, and San Francisco is already celebrating the liquidity event — nmasc_ · 2026-11-19
- Vercel crosses $700M annualized revenue, up 180% YoY, as agents drive deployments — cramforce · 2026-11-19
- Google manual actions surge: risky GEO/AEO tactics triggering scaled content abuse penalties — gaganghotra_ · 2026-11-19